Pad Chivukula, Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT), sold 24,000 shares at $20.76 ($498K) on 2024-10-15, disclosed to the SEC on 2024-10-16.
Scheduled sale ($498k) by Chief Scientific Officer & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.76 | 12,000 | $249K | 50.0% |
| 2 | $20.76 | 12,000 | $249K | 50.0% |
| Total | $20.76 avg | 24,000 | $498K | 100% |
| Filing → |
| ARCT | SELL | 2024-03-27 | $1.2M | — | Filing → |
| ARCT | SELL | 2024-03-21 | $600K | — | Filing → |
| ARCT | SELL | 2023-11-03 | $94K | — | Filing → |